Mark Gelbert joined The Nature’s Bounty Co. as Chief Scientific Officer in October 2017.
Mark is a skilled executive leader with over 30 years of experience in consumer healthcare innovation and brand development. He was most recently Senior Vice President of Global R&D for Pfizer’s $3.5B+ Consumer Healthcare division and a member of its Global Leadership Team. He has been responsible for the launch of hundreds of new consumer drugs, dietary supplements and personal care products globally.
Before joining Pfizer, Mark held R&D leadership roles for Johnson & Johnson, Schering-Plough Healthcare, and Novartis Consumer Healthcare. Mark began his career in Product Development at Procter & Gamble.
Mark has an inherent ability to partner with Marketing, Business Development and Product Supply on growth strategies, and has a deep expertise in Product Development, Regulatory Affairs and Clinical Research in the consumer healthcare setting. He has led the development and implementation of tools and techniques to help organizations evolve their innovation efforts.
Mark has his BA in Chemistry from Rutgers College, and a MS and PhD in Chemistry from the University of Massachusetts, Amherst. He also has his Law Degree from Salmon Chase College of Law.
Mark has held leadership positions in a number of professional organizations, including the Consumer Healthcare Products Association, where he was Chair of the Scientific Affairs Committee and a member of the Board of Directors. Mark currently serves on the Rutgers University Chemistry and Chemical Biology Advisory Board. He is admitted to the Ohio State Bar.